Our mission + values​
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.​

Eluvia is the unrivaled SFA Stent.​
Eluvia™ Drug Eluting Stent (DES) is the only commercially available DES to have been tested – and proven superior – in three separate head-to-head randomised controlled trials.​Eluvia was designed to address the peak of restenosis, providing continuous release of paclitaxel for up to 12 months, unlike other drug-eluting stents which only release it for 2-3 months, ensuring ongoing protection during the critical period.​​
Eluvia Drug-Eluting Stent. Any lesion, Any patient, ZERO DOUBT.​